Prognosis of COVID-19 Patients Requiring Intensive Care Unit Care

Background: There is gobal concern regarding the prognosis of COVID-19 patients requiring care in the Intensive Care Unit (ICU). The aim of this study is to report the demographics, clinical features, comorbidities, imaging findings, and prognosis among critically ill patients with COVID-19 in the ICU. Methods: This retrospective study included patients with laboratory-confirmed COVID-19 infection or clinical and radiological confirmed COVID-19 infection who were admitted to adult ICUs between March 18 and April 22, 2020. Demographic data, the recent exposure history, clinical symptoms, laboratory findings and comorbidities were recorded. Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores were calculated. as well as mechanical ventilation parameters and blood gas results. Results: Twenty-four adult patients were admitted to the ICU with laboratory-confirmed COVID-19 (n = 15) or clinical and radiological confirmed COVID-19 (n = 9). One or more comorbidities were detected in 22/24 of the patients. All patients had abnormal radiography imaging on admission. Twenty patients had bilateral ground-glass opacification on computerized tomography (CT) scan. Almost all patients (23/24) underwent invasive mechanical ventilation therapy. Three patients underwent noninvasive mechanical ventilation. Ten patients died. The mean length of ICU stay in patients who died was 9.6 ± 9 days (2-18 days). The mean length of ICU stay of the four patients who were discharged from the ICU to the floor was 17 ± 12.9 days. The mean length of ICU stay of patients still in the ICU was (n = 10) was 13.36 ± 10.92 days. Conclusion: The vast majority of patients admitted to the ICU with the diagnosis of COVID-19 have multiple co-morbidities, require ventilator support, and experience a high mortality rate.

COVID-19, Intensive care, Viral infection

[1] Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181-92.

[2] De Wit E, van Doremalen N, Falzarano D, Munster, VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523-34.

[3] https://www.who.int/csr/don/

12- january-2020-novel-coronavirus-china/en/. accessed 13 Apr 2020.

[4] https://tr.wikipedia.org/wiki/Turkiye%27de_2020_ koronavir%C3%BCs_pandemisi#cite_note-aa-8. accessed 18 Apr 2020.

[5] https://www.worldometers.info/coronavirus/, accessed 18 Apr 2020.

[6] Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020.

[7] Ranieri VM, Rubenfeld GD, Thompson BT, Thompson Tb, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-33.

[8] Singer M, Deutschman CS, Seymour CW, Msc MS, Annane D, BauerM, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801-810.

[9] https://www.sccm.org/getattachment/Disaster/SSC-COVID19-Critical-Care-Guidelines.pdf. 18 Apr 2020.

[10] T. C. Ministry of Health general directorate of public health, COVID-19 (SARS-CoV-2 infection guide, Ankara. 2020. accessable on: https://covid19bilgi.saglik.gov.tr/depo/tedavi/COVID19-EriskinHastaTedavisi.

[11] World Health Organization. Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans. 2020. accessable on: https://www.who/int/emergencies/diseases/novel–coronavirus-2019/technical-guidance/laboratory–guidance.

[12] Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020.

[13] Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475-481.

[14] Huang C, Wang Y, Li X, Ren L., Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.

[15] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical char-acteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.

[16] Grasselli, G, Zangrillo, A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020.

[17] Bai HX, Hsieh B, Xiong Z, Halsey, K, Choi, JW, Tran, TML, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020.

[18] Ai T, Yang Z, Hou H. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020;26:200642.

[19] Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020.

[20] Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020.

[21] Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the NewYork City Area. JAMA. 2020.